The 20 Best Alternating Hemiplegia of Childhood Doctors Near Me in Ann Arbor, MI

After graduating from Tehran University of Medical Sciences in 1990, Dr. Sohrab spent time in Spinal Cord Injury Centers of Iran, in multiple capacities, organizing care and educating different levels of practitioners in providing care for veterans of war. He then spent a few years of general practice, in different parts of Iran, dedicated to providing medical care and organizing Public Health Services, in rural areas. Dr. Sohrab has been practicing, and teaching, general Neurology at the University of Michigan, since 2012. Dr. Sohrab is rated as an Experienced provider by MediFind in the treatment of Alternating Hemiplegia of Childhood. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Migraine, Vertigo, Migraine with Brainstem Aura, and Trigeminal Neuralgia.

Dr. Schmidt attended medical school at Michigan State University, and completed her residency training in PM&R at the University of Pittsburgh Medical Center where she also served as chief resident. Dr. Schmidt's clinical responsibilities include outpatient practice focusing on transition into adulthood for pediatric patients with disabilities, cerebral palsy, amyotrophic lateral sclerosis and other neuromuscular conditions. Dr. Schmidt is rated as an Advanced provider by MediFind in the treatment of Alternating Hemiplegia of Childhood. She is also highly rated in 49 other conditions, according to our data. Her clinical expertise encompasses Dysferlinopathy, Spinal Muscular Atrophy (SMA), Spinal Muscular Atrophy Type 3, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

Wayne Cornblath is a Neurologist and an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Cornblath is rated as an Experienced provider by MediFind in the treatment of Alternating Hemiplegia of Childhood. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Optic Neuritis, Myasthenia Gravis, Increased Intracranial Pressure, and Benign Essential Blepharospasm.

Stephen Goutman, MD, MS is an Associate Professor in the Department of Neurology and Director of the Amyotrophic Lateral Sclerosis Clinic and ALS Center of Excellence at Michigan Medicine. After obtaining a degree in neuroscience at the Johns Hopkins University (Baltimore, MD), Dr. Goutman completed his medical degree at the University of Chicago Pritzker School of Medicine (Chicago, IL) and his neurology residency and neuromuscular fellowship at Cleveland Clinic (Cleveland, OH). He received a Master’s in Clinical Research Design and Statistical Analysis at the University of Michigan (Ann Arbor, MI).Dr. Goutman evaluates and treats patients with neuromuscular diseases and is interested in diseases such as myasthenia gravis and muscle diseases. His area of expertise is amyotrophic lateral sclerosis (ALS)/Lou Gehrig’s Disease where his focus is delivering comprehensive and compassionate care. He is Director of the ALS Clinic, an ALS Association Certified Center of Excellence (http://www.umich-als.org/), where he leads a team of providers that care for persons with ALS and their families. Dr. Goutman is inspired by his patients and thus aims to provide the highest level of care.Dr. Goutman’s research is focused on identifying causes of and treatments for ALS. He leads research efforts that received funding by the National Institutes of Health and the Centers for Disease Control aimed at identifying environmental risk factors and causes of ALS (https://umhealthresearch.org/#studies/HUM00028826) and showed, in an article that received widespread attention, a connection between ALS and organochlorine pesticides (https://jamanetwork.com/journals/jamaneurology/fullarticle/2519875). Dr. Goutman also helps direct the University of Michigan ALS Biorepository which provides essential resources to ALS researchers within and external to the University of Michigan enabling studies into areas of ALS genetics, epigenetics, and immunology.Dr. Goutman is a site principal investigator of several multisite clinical trials focused on identifying new ALS treatments and causes and is an active participant with the Northeast ALS Consortium (NEALS) to improve care for ALS. He received a 2016 Young Investigator Award by the World Federation of Neurology Research Group on Motor Neuron Diseases. Dr. Goutman is rated as an Experienced provider by MediFind in the treatment of Alternating Hemiplegia of Childhood. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Spinal and Bulbar Muscular Atrophy. Dr. Goutman is board certified in Neurology, Neuromuscular Medicine, and Electrodiagnostic Medicine.

Dr. Feldman is the director of the NeuroNetwork for Emerging Therapies at Michigan Medicine and the ALS Center of Excellence at Michigan Medicine. The latter includes the Pranger ALS Clinic, one of the top multidisciplinary clinics caring for those suffering from amyotrophic lateral sclerosis (ALS). She serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease.Dr. Feldman is a compassionate and dedicated physician who cares deeply about her patients. She has been recognized for her clinical excellence by numerous organizations and is annually named as one of the “Best Doctors in America.” Her forward-thinking, collaborative, multidisciplinary approach has transformed how neurodegenerative diseases are diagnosed, treated, and prevented.Dr. Feldman has made significant contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. She has authored over 530 peer-reviewed publications, 74 book chapters, and 5 books on the pathology, diagnosis, and treatment of neurological diseases. Dr. Feldman has been continuously funded by the NIH since 1989 and is currently the principal or co-investigator of numerous clinical trials and grants. She has received numerous awards and honors throughout her remarkable career, including the University of Michigan’s Early Distinguished Career Award, the Distinguished Faculty Achievement Award, and the Distinguished Alumnus Achievement Award. She was also the first woman in 25 years to receive the Robert S. Schwab Award from the American Clinical Neurophysiology Society. In 2022, Dr. Feldman was awarded the University of Michigan Distinguished Professorship, the highest faculty honor at University of Michigan.Dr. Feldman is actively committed to and involved in professional service. She served as President of the Peripheral Nerve Society from 2007-2009 and President of the American Neurological Association (ANA) from 2011-2013. Dr. Feldman is an elected member of the National Academy of Medicine (NAM) and Association of American Physicians, and a Fellow of the American Association for the Advancement of Science. Dr. Feldman is the Editor of the Contemporary Neurology Series and also serves on a number of editorial boards for leading scientific journals, including The Lancet Neurology, Nature Reviews Neurology, JAMA Neurology and Journal of Neurology, Neurosurgery and Psychiatry. Dr. Feldman is rated as an Experienced provider by MediFind in the treatment of Alternating Hemiplegia of Childhood. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Autonomic Neuropathy. Dr. Feldman is board certified in Neurology and Electrodiagnostic Medicine.

Dr. Bowman completed her residency in Physical Medicine and Rehabilitation at Wayne State University/Detroit Medical Center in 2017. She then completed a Pediatric Rehabilitation Medicine fellowship at the University of Michigan in 2019. Dr. Bowman sees pediatric patients with a variety of conditions, including TBI, SCI, Cerebral Palsy, Neuromuscular diseases, and other conditions affecting development. Dr. Bowman is rated as an Experienced provider by MediFind in the treatment of Alternating Hemiplegia of Childhood. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Myotonia Congenita, Spasticity, and Spastic Diplegia Infantile Type.

Dr. Ayyangar developed and directs several Pediatric Rehabilitation programs at the University of Michigan including the Pediatric Rehabilitation Medicine Fellowship Program, and the intrathecal baclofen program. She was also instrumental in developing the injection under sedation program for botulinum toxin and phenol injections and initiating the use of US guidance for injections in the pediatric population. She has a particular affinity for the management of children with complex needs and is currently actively involved in the Pediatric Palliative Care Service, and is board certified in Hospice and Palliative Medicine (as well as pediatrics, PM&R, and pediatric rehabilitation medicine.) She has served on the AAPM&R Board of Governors as well as several academy committees. She was Vice Chair and Chair of the Council for Pediatric Rehabilitation/Developmental Disabilities and received the 2015 AAPM&R Outstanding Council Service Award. Dr. Ayyanagar has made national and international presentations on topics related to spasticity management and cerebral palsy and has received several honors including recognition as one of the Best Doctors in America as a pediatric specialist in 2013, 2014 and 2015 by US News and World Report. Dr. Ayyangar is rated as an Experienced provider by MediFind in the treatment of Alternating Hemiplegia of Childhood. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Spastic Diplegia Infantile Type, Spasticity, and Focal Dystonia. Dr. Ayyangar is board certified in Pediatric Rehabilitation Medicine and Physical Medicine & Rehab.

Vikram Shakkottai is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Shakkottai is rated as an Experienced provider by MediFind in the treatment of Alternating Hemiplegia of Childhood. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, Spinocerebellar Ataxia Type 1, and Drug Induced Dyskinesia.

Dr. Chiodo is co-director for U-M SCIMS and has been the clinical director of Spinal Cord Injury Medicine at the University of Michigan since 2002. He has worked on the U-M SCIMS research projects, Wellness in SCI and Predictors of Health, and Quality of Life in Persons with Ventilator Assistance after SCI. He has published several manuscripts on pain management, wellness in SCI, and is preparing several manuscripts on ventilator weaning after SCI. He has served as a co-investigator for two clinical trials of Fampridine’s efficacy after SCI: as treatments for spasticity and for restrictive lung disease.Dr. Chiodo is the primary attending physician for SCI services in the UMHS Adult Rehabilitation Unit, coordinating all clinical services. Dr. Chiodo is rated as an Experienced provider by MediFind in the treatment of Alternating Hemiplegia of Childhood. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Spasticity, Autonomic Dysreflexia, Paraplegia, and Spinal Stenosis. Dr. Chiodo is board certified in Pain Medicine, Physical Medicine & Rehab, Spinal Cord Injury Medicine, and Electrodiagnostic Medicine.